Table 1.
Vaccination schedules and model information for the ten considered pathogens
| Vaccination schedule | Lead institution for model (model type) | |
|---|---|---|
| Hepatitis B virus | Birth dose and three infant doses (<1 year) | Center for Disease Analysis (dynamic); Imperial College London (dynamic); independent model developed by Goldstein and colleagues15 (static) |
| Human papillomavirus | Two doses for adolescent girls (9–14 years) | Harvard School of Public Health (static); LSHTM (static) |
| Haemophilus influenzae type B | Three infant doses (<1 year) | Johns Hopkins University (static); LSHTM (static) |
| Japanese encephalitis | Infant dose (<1 year) | Oxford University (dynamic); University of Notre Dame (dynamic) |
| Measles | First dose at ≤1 year, second dose at <2 years | LSHTM (dynamic); Pennsylvania State University (dynamic) |
| Neisseria meningitidis serogroup A | Infant dose (<1 year) | University of Cambridge (dynamic); Kaiser Permanente Washington (dynamic) |
| Streptococcus pneumoniae (PCV) | Three infant doses (<1 year) | Johns Hopkins University (static); LSHTM (static) |
| Rotavirus | Two infant doses (<1 year) | Johns Hopkins University (static); LSHTM (static) |
| Rubella | First dose at <1 year, second dose at <2 years | Johns Hopkins University (dynamic); Public Health England (dynamic) |
| Yellow fever | Infant dose (<1 year) | Imperial College London (static) |
Detailed descriptions of the models are provided in appendix 2 (pp 14–35). LSHTM=London School of Hygiene & Tropical Medicine. PCV=pneumococcal conjugate vaccine.